Overview

A Study to Compare the Effects of Sarpogrelate Sustained Release /Aspirin Combination Therapy Versus Aspirin on Blood Viscosity in the Patients With Peripheral Arterial Disease and Coronary Artery Disease

Status:
Recruiting

Trial end date:
2024-02-28

Target enrollment:

Participant gender:

Summary

This study is to compare the effects of sarpogrelate sustained release /aspirin combination therapy versus aspirin on blood viscosity in the patients with peripheral arterial disease and coronary artery disease

Phase:

Phase 4

Details

Lead Sponsor:

Yuhan Corporation

Treatments:

Aspirin
Sarpogrelate